The Center for Aquaculture Technologies Canada (CATC) is now an independent entity.
Photo: CATC.
The US-based Center for Aquaculture Technologies (CAT) has announced the spinout of its Canadian subsidiary, Center for Aquaculture Technologies Canada (CATC), into an independent entity.
The reconfiguration is set to enable both entities to focus on further developing their core strengths, with CAT continuing its work on advancing aquaculture genetics, while CATC spearheads innovations in aquatic animal health and nutrition.
Both CAT and CATC will continue as sister companies within the Cuna del Mar portfolio, the organizations said in a press announcement.
“The realignment empowers CAT to pursue innovation in genetic improvement with singleness of purpose and strategic focus," said CAT CEO John Buchanan.
Headquartered in San Diego, California, CAT has made significant investments in genome editing, particularly in developing core intellectual property to produce 100% sterile fish for farming, combining genome editing with genotyping, genomics, and selective breeding.
"We are excited about the opportunities in bringing our genome editing technologies to commercial impact while honoring environmental stewardship. We have a world class team in all genetics disciplines, are committed to client success, and are excited about the future," Buchanan said.
"This will also allow CATC to pursue strategic initiatives in health and nutrition with agility and allow both teams to focus on innovation," he added.
Continuity in senior management and frontline teams will ensure both organizations maintain their high-quality service standards, the companies said.
Meanwhile, new Canadian entity CATC will continue to operate its facilities in Souris and Victoria, Prince Edward Island.
As a contract research organization with Good Manufacturing Practice (GMP) release capabilities, CATC will retain its focus on health and nutrition for aquatic animals, supported by diagnostic services and a commercial-scale feed extruder.
Newly appointed CEO of CATC, Myrna Gillis said the new business configuration "presents us with a unique opportunity to deepen our expertise in health, nutrition, diagnostics, and specialty feed production while forging new pathways for research and development."
"We are excited about the prospects this brings and are committed to driving meaningful contributions to the growth of the aquaculture sector," she added.
Gillis, who has overseen CAT's health and nutrition work since November 2023, also thanked founder John Buchanan for his vision and leadership. CATC plans to release additional information soon.
